A Novel Role of Fragile-X Mental Retardation Protein in Mitochondrial Calcium Homeostasis
A Novel Role of Fragile-X Mental Retardation Protein in Mitochondrial Calcium Homeostasis
批准号:
10612482
负责人:
Bingwei Lu
金额:
$19.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-01 至 2024-04-30
关键词:
AffectApoptosisBehaviorBehavioralBehavioral SymptomsBiochemicalBioenergeticsBiological ProcessBiologyBrainBrain DiseasesBuffersCalciumCellsCellular StructuresCitric Acid CycleClinicalCognitionComplexDefectDevelopmentDifferentiation and GrowthDiseaseDrosophila genusElectron TransportEmotionsEnzymesEtiologyFMR1FaceFibroblastsFoundationsFragile X SyndromeFunctional disorderFutureGeneticGoalsHealthHealthcareHomeostasisHumanHyperphagiaImageInduced pluripotent stem cell derived neuronsInheritedIntellectual functioning disabilityInvestigationKnowledgeLinkMediatingMental disordersMessenger RNAMetabolicMetabolismMitochondriaModelingMolecularNeurobehavioral ManifestationsNeurodegenerative DisordersNeuronsObesityOrganellesOutputPathogenesisPathogenicityPathologicPatient CarePatientsPhysiologicalPositioning AttributeProcessProductionProtein DeficiencyProteinsRNARNA BindingRNA-Binding ProteinsRegulationRoleSeizuresSignal TransductionSiteSocial BehaviorStructureSymptomsSynapsesSynaptic TransmissionSynaptic plasticitySystemTestingTranslationsTreatment FailureVoltage-Dependent Anion Channelautism spectrum disorderbehavioral phenotypingdFMR1 geneeffective therapyflyin vivomRNA Translationmitochondrial dysfunctionneural circuitneurophysiologyneuropsychiatric disordernovelnovel therapeutic interventionpharmacologicprotein functionprotein protein interactiontreatment effecttreatment strategyuptake
中文摘要
脆性X综合征(FXS)是遗传性智力残疾的最常见形式,
自闭症的原因FXS是由编码脆性X染色体智力低下的Fmr 1基因表达缺失引起的
蛋白(FMRP),一种具有RNA结合活性的蛋白,被认为主要作为翻译调节因子。在
除了智力残疾,FXS患者还表现出行为和认知症状,不规则的身体状况,
特征和代谢症状FXS发病机制的流行假说将FMRP假定为
一种混杂的RNA结合蛋白,靶向数百种脑RNA,改变了这些mRNA的翻译
靶点是突触和神经回路缺陷的根本原因,
FXS。然而,最近针对一些关键的翻译的治疗策略的临床失败,
FMRP的底物,以及目前缺乏FXS的有效治疗选择,认为新的研究
FMPR的生物学功能和FXS新的致病机制是必要的。
线粒体是一种动态的复杂细胞器,在生物学的许多方面都发挥着重要作用,
能量产生和中间代谢到细胞内信号传导和凋亡。这些广泛的功能
将安东定位为人类健康的核心参与者。在神经元中,线粒体和突触
有联系除了它们在生物能量学中的中心作用之外,线粒体对于维持细胞的存活也是至关重要的。
细胞内钙稳态。线粒体的Ca 2+摄取有助于缓冲细胞质Ca 2+瞬变,
神经元活化,保护免受Ca 2+内流的有害影响。ER-线粒体接触位点
(ERMCS)越来越多地被认为是调节线粒体-Ca 2+稳态的关键结构,
ERMCS和线粒体Ca 2+改变在神经退行性疾病发病机制中的新作用。是否
ERMCS及其在线粒体-Ca 2+稳态中的作用在主要神经精神疾病如FXS中受到影响,
知道的该提案的目标是测试中心假设,即FMRP在ERMCS中物理作用,
细胞器之间的Ca 2+信号传导,在这个过程中的缺陷有助于FXS的病因。为了验证这一
假设,我们建议在这个探索性项目中实现以下具体目标:目标1。检查缺陷
在果蝇dFmr 1模型和FXS患者衍生模型中ERMCS的形成。目标2.测试
ERMCS蛋白在介导FMRP功能中指导线粒体-Ca 2+稳态的生理作用。通过
为ERMCS和mito-Ca 2+参与介导细胞器FMRP功能提供了证据,
突触和有机体水平,这些研究将为未来的机制研究奠定基础,
FMRP在正常突触和神经元过程中的调节和功能是脑功能,认知,
情绪和社会行为。这项研究的结果有望大大提高我们对
线粒体和Ca 2+信号在FXS和各种相关精神障碍中的基本作用,
为患有这些毁灭性精神疾病的患者提供医疗保健的新颖而合理的战略。
英文摘要
Fragile X syndrome (FXS) is the most prevalent form of inherited intellectual disability and the primary genetic
cause of autism. FXS is caused by loss of expression of the Fmr1 gene encoding Fragile X Mental Retardation
Protein (FMRP), a protein with RNA-binding activity thought to act primarily as a translational regulator. In
addition to intellectual disability, FXS patients present behavioral and cognitive symptoms, irregular physical
features, and metabolic symptoms. The prevailing hypothesis of FXS pathogenesis posits FMRP as a
promiscuous RNA-binding protein targeting hundreds of brain RNAs, with altered translation of these mRNA
targets as the underlying cause of the synaptic and neural circuit defects and behavioral phenotypes seen in
FXS. However, the recent clinical failures of treatment strategies targeting some of the key translational
substrates of FMRP, and the current lack of effective treatment option for FXS, argue that investigations of new
biological function of FMPR and new pathogenic mechanisms of FXS are warranted.
Mitochondria are dynamic and complex organelles with essential roles in many aspects of biology, from
energy production and intermediary metabolism to intracellular signaling and apoptosis. These broad functions
position mitochondrion as a central player in human health. In neurons, mitochondria and synapses are intimately
linked. In addition to their central role in bioenergetics, mitochondria are also critically important for maintaining
cellular Ca2+ homeostasis. Ca2+ uptake by mitochondria helps buffer cytosolic Ca2+ transients arising from
neuronal activation, protecting against the detrimental effects of Ca2+ influx. The ER-mitochondria contact site
(ERMCS) are increasingly appreciated as key structures regulating mito-Ca2+ homeostasis, and there is an
emerging role of altered ERMCS and mito-Ca2+ in the pathogenesis of neurodegenerative diseases. Whether
ERMCS and its role in mito-Ca2+ homeostasis is affected in major neuropsychiatric diseases such as FXS is not
known. The goal of this proposal is to test the central hypothesis that FMRP acts physically at ERMCS to direct
Ca2+ signaling between organelles, and that defects in this process contribute to the etiology of FXS. To test this
hypothesis, we propose to achieve the following Specific Aims in this exploratory project: Aim 1. Examine defects
in ERMCS formation in the Drosophila dFmr1 model and FXS patient-derived models. Aim 2. Test the
physiological roles of ERMCS proteins that direct mito-Ca2+ homeostasis in mediating FMRP function. By
providing evidence for the involvement of ERMCS and mito-Ca2+ in mediating FMRP function at the organellar,
synaptic, and organismal levels, these studies will lay the foundation for future mechanistic studies on the
regulation and function of FMRP in normal synaptic and neuronal processes underlying brain function, cognition,
emotion, and social behavior. Results from this study promise to significantly advance our understanding of the
fundamental roles of mitochondria and Ca2+ signaling in FXS and various related mental disorders and offer
novel and rational strategies to deliver health care for patients suffering from these devastating mental illnesses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reverse electron transport and tauopathy
-
批准号:10740115
-
项目类别:
-
资助金额:$19.36万
-
财政年份:2023
-
负责人:Bingwei Lu
-
依托单位:
A Novel Role of Fragile-X Mental Retardation Protein in Mitochondrial Calcium Homeostasis
-
批准号:10452354
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2022
-
负责人:Bingwei Lu
-
依托单位:
Interplay between amyloid precursor protein metabolism and ER-mitochondria contact
-
批准号:10301076
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2021
-
负责人:Bingwei Lu
-
依托单位:
Interplay between amyloid precursor protein metabolism and ER-mitochondria contact
-
批准号:10470218
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2021
-
负责人:Bingwei Lu
-
依托单位:
Understanding SHRF, an RNA exosome-linked disease with multi-organ involvement
-
批准号:10305689
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2020
-
负责人:Bingwei Lu
-
依托单位:
Mitochondrial inner membrane architecture in skeletal muscle pathophysiology
-
批准号:10317296
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2020
-
负责人:Bingwei Lu
-
依托单位:
Mitochondrial inner membrane architecture in skeletal muscle pathophysiology
-
批准号:10441283
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2019
-
负责人:Bingwei Lu
-
依托单位:
Mitochondrial inner membrane architecture in skeletal muscle pathophysiology
-
批准号:9979767
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2019
-
负责人:Bingwei Lu
-
依托单位:
Mitochondrial inner membrane architecture in skeletal muscle pathophysiology
-
批准号:10657388
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2019
-
负责人:Bingwei Lu
-
依托单位:
Mitochondrial inner membrane architecture in skeletal muscle pathophysiology
-
批准号:10208725
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2019
-
负责人:Bingwei Lu
-
依托单位:
Exploring the mitochondrial function of TSEN in neuronal development and maintenance
-
批准号:9353477
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2016
-
负责人:Bingwei Lu
-
依托单位:
Exploring the mitochondrial function of TSEN in neuronal development and maintenance
-
批准号:9264212
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2016
-
负责人:Bingwei Lu
-
依托单位:
Using Human iDNs to Study Translational Control of Neuronal Function and Survival
-
批准号:9195564
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2016
-
负责人:Bingwei Lu
-
依托单位:
Using Human iDNs to Study Translational Control of Neuronal Function and Survival
-
批准号:9336991
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2016
-
负责人:Bingwei Lu
-
依托单位:
Linking the Mitochondrial and Epigenetic Pathways of Life Span Extension
-
批准号:8698065
-
项目类别:
-
资助金额:$20.06万
-
财政年份:2014
-
负责人:Bingwei Lu
-
依托单位:
Molecular Genetic Analysis of TORC1 and TORC2 Signaling in Neuronal Maintenance
-
批准号:10284700
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2013
-
负责人:Bingwei Lu
-
依托单位:
Molecular Genetic Analysis of TORC1 and TORC2 Signaling in Neuronal Maintenance
-
批准号:9197705
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2013
-
负责人:Bingwei Lu
-
依托单位:
Molecular Genetic Analysis of TORC1 and TORC2 Signaling in Neuronal Maintenance
-
批准号:10613960
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2013
-
负责人:Bingwei Lu
-
依托单位:
Genetic control of neural stem cell homeostasis
-
批准号:10201754
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2013
-
负责人:Bingwei Lu
-
依托单位:
Molecular Genetic Analysis of TORC1 and TORC2 Signaling in Neuronal Maintenance
-
批准号:10381512
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2013
-
负责人:Bingwei Lu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: